Perigon Wealth Management’s PAVmed PAVM Stock Holding History

Perigon Wealth Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-22	Closed	-$44K	–	527
2021 Q1	$44K	Buy	+22	New	+$33.1K	﹤0.01%	488

Other funds holding PAVM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EGI

EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return

Perigon Wealth Management's PAVM Position: Q2 2021 in Review

Perigon Wealth Management sold out of PAVmed (PAVM) in Q2 2021, closing a stake of 22 shares — an estimated $44K sold.

Perigon Wealth Management first reported a position in PAVM in Q1 2021 and held it in 1 quarter. The position peaked at $44K in Q1 2021. 97 funds tracked by Wall St. Rank hold PAVM as of Q2 2021.

Perigon Wealth Management reported no remaining PAVmed position as of Q2 2021 after selling out during the quarter.
Perigon Wealth Management sold 22 PAVmed shares in Q2 2021, an estimated $44K.
Perigon Wealth Management first reported a position in PAVmed in Q1 2021 and held it in 1 quarter.
Perigon Wealth Management's PAVmed position peaked at $44K in Q1 2021.
97 funds tracked by Wall St. Rank held PAVmed as of Q2 2021.

Based on Perigon Wealth Management's 13F filing for Q2 2021, filed 19 Jul 2021.